Representing Shareholders, Employees, and Consumers for Over 30 Years
MiMedx_logo_CMYK.png

News

News & Investigations

News and Investigations

We're actively investigating new cases on behalf of consumers, employees, and shareholders. If you've purchased any of these consumer products or own stock in any of these companies, please contact us to discuss your legal rights.

 

FDA Warns Gojo for False and Misleading Advertisng of Purell Products

Schubert Law Firm Investigating Potential Class Action After FDA Warns Gojo That Its Claims That Purell Prevents Illnesses Are Unsubstantiated and Unlawful

Schubert Jonckheer & Kolbe today launched an investigation into the conduct of Gojo Industries, Inc. for false and misleading statements in connection with its Purell products. In a letter on January 17, 2020, the Food and Drug Administration formally warned the company that its claims that Purell could reduce the potential for infection or prevent illnesses were unsubstantiated and violated federal law.

On its websites and social media, Gojo claimed that Purell “kills more than 99.99% of most common germs that may cause illness in a healthcare setting, including MRSA & VRE.” According to the FDA, the company also made numerous statements that clearly indicate that Purell is “intended for reducing or preventing disease from the Ebola virus, norovirus, and influenza.”

900.jpg

However, “the FDA is currently not aware of any adequate and well-controlled studies demonstrating that killing or decreasing the number of bacteria or viruses on the skin by a certain magnitude produces a corresponding clinical reduction in infection or disease caused by such bacteria or virus.” Accordingly, the FDA reclassified Purell products as unapproved new drugs marketed in violation of federal law “because they are not generally recognized as safe and effective for use under the conditions prescribed, recommended, or suggested in their labeling.”

In light of the FDA’s warning letter, the Schubert Firm is investigating whether Gojo’s marketing of its Purell products is false and misleading in violation of state and federal laws. The following Purell products, in various sizes and packages, are subject to the FDA’s warning letter:

  • PURELL Healthcare Advanced Hand Sanitizer Gentle & Free Foam

  • PURELL Healthcare Advanced Hand Sanitizer Gel

  • PURELL Healthcare Advanced Hand Sanitizer Foam

  • PURELL Healthcare Advanced Hand Sanitizer Gentle & Free Foam ES6 Starter Kit

  • PURELL Healthcare Advanced Hand Sanitizer ULTRA NOURISHING Foam

If you purchased one of these Purell products based on the claims that they prevent illnesses or reduce the potential for infection, you may be able to participate in a class action lawsuit seeking money damages and an end to any false and misleading advertising.

If you purchased a Purell product and would like to learn more about your legal rights—or would like to participate in the class action lawsuit—please complete the form below.